Congress Must Act to Bring Needed Reforms to the 340B Drug Pricing Program: Majority Staff Report
Link
Description
Presents findings from a U.S. Senate Committee on Health, Education, Labor & Pensions majority staff report on how covered entities generate and use revenue from the 340B Drug Pricing Program and how patients benefit from the program. Describes data and information collected from hospital covered entities, Bon Secours Mercy Health and Cleveland Clinic; Federally Qualified Health Center (FQHC) covered entities, Sun River Health and Yakima Valley Farm Workers Clinic; contract pharmacies, CVS Health and Walgreens; and drug manufacturers, Eli Lilly and Amgen. Includes rural references throughout.
Date
04/2025
Organization
Senate Committee on Health, Education, Labor & Pensions
Tagged as
Federally Qualified Health Centers
· Healthcare business and finance
· Hospitals
· Pharmacy and prescription drugs
· Policy
· Statistics and data
· New York
· Ohio
· Virginia
· Washington
Related Content
Organizations (1)
- Senate Committee on Health, Education, Labor & Pensions, view details